Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check4 days agoChange DetectedThe study record history now shows an added revision entry for v3.3.4, replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a new revision entry (v3.3.3) to the record history. Removed the HHS Vulnerability Disclosure link and the older revision entry v3.3.2.SummaryDifference0.2%

- Check47 days agoChange DetectedA new site revision entry v3.3.2 appears in the history, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.3.1) was added to the record history. An older revision (v3.2.0) was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedA government funding lapse notice at the top of the page was removed; the rest of the study record page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check76 days agoChange DetectedThe new screenshot shows the same record history page with identical version entries and no visible updates to the trial's core details (status, description, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.